Novo Nordisk A/S
What’s next for the Biden administration’s Medicare drug price negotiations
U.S. President Joe Biden and Vice President Kamala Harris walk out together, at an event on Medicare drug price negotiations, in Prince George’s County, Maryland, U.S., August 15, 2024. Ken Cedeno | Reuters The Biden administration on Thursday reached a milestone in Democrats’ decades-long quest to use Medicare to drive down prescription drug costs, releasing […]
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and […]
Read More
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Novo Nordisk and Eli Lilly have so far dominated the booming market for a class of weight loss and diabetes drugs. […]
Read More
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s. Most insurance plans cover GLP-1s when they are used to treat diabetes, so those patients can usually avoid the roughly […]
Read More
Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching
Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its competing drug Wegovy in the second quarter. Novo Nordisk shocked investors on Wednesday when its latest results fell short of Wall Street’s expectations. Shares are reeling, down 8%, after […]
Read More
Stocks making the biggest moves midday: Fortinet, Shopify, Lyft and more
Check out the companies making headlines in midday trading. Fortinet – The cybersecurity stock was the biggest advancer in the S & P 500 on Wednesday, surging 26% after Fortinet posted a strong second-quarter report, as well as upbeat current quarter guidance. The cybersecurity company posted adjusted quarterly earnings of 57 cents per share on […]
Read More
Stocks making the biggest moves premarket: Disney, Airbnb, Rivian, Amgen and more
Check out the companies making headlines before the bell. Disney — Shares were down about 1% after the media giant reported quarterly results that beat analyst expectations, thanks in part to strong performance at its streaming unit. The company earned $1.39 per share, excluding items, on revenue of $23.16 billion. Analysts expected a profit of […]
Read More
Stock futures rise after Wall Street snaps three days of losses: Live updates
Traders work on the floor of the New York Stock Exchange during morning trading on February 23, 2024 in New York City. Michael M. Santiago | Getty Images Stock futures were higher on Tuesday evening after Wall Street snapped a three-day string of declines. Futures tied to the S&P 500 gained 0.6%, while Nasdaq 100 […]
Read More
Want to invest $50,000? Here are 5 ETFs to buy and hold, according to a wealth manager
2024 was expected to be a ” stock picker’s year ,” but macroeconomic uncertainties and some market volatility have seen many investors plow cash into exchange-traded funds (ETFs). Net flows into ETFs topped $200 million in the second quarter of this year, according to Fidelity, taking the year’s total to $404 billion — 85% higher […]
Read More
Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug […]
Read More